The First Clinical Research Training Course for SAHZU Department Heads at the Harvard T.H. Chan School of Public Health (HSPH) was successfully held from June 9 to June 14, 2024.
SAHZU signed an agreement with the Association of Radiologists of the Kyrgyz Republic (ARKR) on May 25.
From May 27 to May 31, SAHZU Vice President Prof. DING Kefeng led a SAHZU colorectal surgeon delegation of five members to visit four Italian hospitals in Rome, Naples and Treviso, and was invited to attend the Italian Colorectal Surgery Spring Meeting 2024 as a keynote speaker.
Invited by CSI Frankfurt 2024, the top academic event on interventional cardiology in the international community, SAHZU Chairman Prof. WANG Jian'an and his team demonstrated one transcatheter edge to edge mitral repair (TEER) and one Liwen Procedure on the conference.
A new study led by SAHZU researchers has identified ways by which some microbes might influence cancer immunotherapy, suggesting a potential microbial-based adjuvant approach to improve the responsiveness of immunotherapy. Their results were published in Cell in March 2024.
Chair of SAHZU Radiation Oncology Prof. WEI Qichun and his team, for the first time, revealed the critical role of PORT in early-stage OTSCC. Their article titled Impact of Postoperative Radiotherapy on the Prognosis of Early-Stage (pT1-2N0M0) Oral Tongue Squamous Cell Carcinoma was published in Journal of Clinical Oncology on April 1.
SAHZU, SAHZU Eye Center and SNEC together signed a MoU to jointly promote collaboration in research innovation and faculty training in ophthalmology, with an ultimate goal to make adequate contribution to the global ophthalmology community.
A delegation from E.Meshalkin National Medical Research Center of the Ministry of Health of Russia visited SAHZU from March 27 to March 30.
From March 11 to 15, SAHZU President Prof. WANG Weilin and a SAHZU multidisciplinary team paid a visit to Uzbekistan for a five-day surgical operation demonstrations and academic exchange activities
Tuesday, SAHZU and National Heart Centre Singapore (NHCS) signed a memorandum of understanding (MOU) to collaborate on clinical and translational research in cardiology, as well as to work on education of clinical and/or research staff.
A new study led by SAHZU researchers has identified ways by which some microbes might influence cancer immunotherapy, suggesting a potential microbial-based adjuvant approach to improve the responsiveness of immunotherapy. Their results were published in Cell1 in March 2024.
Italian surgeons Drs. Michele Cricrì and Federico Mongardini and Mexican surgeon Dr. Mitre Reyes have recently completed a three-month clinical training program at SAHZU Colorectal Surgery, as the second group of trainees of International Colorectal Surgery Training Academy of China (ICSTAC).
Dr. Lim Shin Hoei is an anesthesiologist from Penang, Malaysia. She was trained at SAHZU for trans-esophageal echocardiogram (TEE) and cardiothoracic anesthesia for six months. Congratulation to Dr. Lim!